Literature DB >> 9846970

Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.

A Roetger1, A Merschjann, T Dittmar, C Jackisch, A Barnekow, B Brandt.   

Abstract

Overexpression of the crbB-2 gene-encoded p185(c-erbB-2) is correlated with early onset of metastasis in breast cancer patients. Furthermore, the detection of blood-borne epithelium-derived clustered cells expressing p185(c-erbB-2) was related to advanced stages in breast cancer. To further elucidate the receptor's function in the metastatic process of human breast cancers, we analyzed disaggregated cells and cell clusters from freshly dissected breast cancer tissues. We studied whether their capability of extravasation is correlated with their expression of c-erbB-2. A model for the venular wall was constructed by growing human umbilical vein endothelial cells (HUVECs) on porous membranes coated with basement membrane extracellular matrix. In four control breast cancer cell lines (SK-BR-3, MCF-7, MDA-MB-468, and MDA-MB-468, the latter transfected with a full-length c-erbB-2 cDNA vector) producing different levels of the c-erbB-2 receptor, the expression level correlated positively with the invasiveness of the cells. The invasive, predominantly clustered cells from 14 of 23 tumors were positively stained for p185(c-erbB-2) by immunocytochemistry. Furthermore, we show that the invasive cell populations express the metastasis-associated proteins matrix metalloproteinase MMP-2, CD44, and integrins alpha(v)beta3 and alpha6. In this first study on the behavior of cells and cell clusters from disaggregated operated cancers in an extravasation model, we could demonstrate the presence of c-erbB-2-expressing cell subpopulations within the individual breast cancers that are presumably of high metastatic potential.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846970      PMCID: PMC1866322          DOI: 10.1016/S0002-9440(10)65694-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  An optimized culture medium for human vascular endothelial cells from umbilical cord veins.

Authors:  P Friedl; D Tatje; R Czpla
Journal:  Cytotechnology       Date:  1989-08       Impact factor: 2.058

Review 2.  Involvement of alpha 6 and alpha v integrins in metastasis.

Authors:  B A Imhof; L Piali; R H Gisler; D Dunon
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

Review 3.  Interactions between CD44 and hyaluronic acid: their role in tumor growth and metastasis.

Authors:  M S Sy; D Liu; R Schiavone; J Ma; H Mori; Y Guo
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

4.  Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.

Authors:  R Falcioni; A Antonini; P Nisticò; S Di Stefano; M Crescenzi; P G Natali; A Sacchi
Journal:  Exp Cell Res       Date:  1997-10-10       Impact factor: 3.905

5.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

6.  Stability of HER-2/neu expression over time and at multiple metastatic sites.

Authors:  G A Niehans; T P Singleton; D Dykoski; D T Kiang
Journal:  J Natl Cancer Inst       Date:  1993-08-04       Impact factor: 13.506

7.  Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

Authors:  B A Gusterson; R D Gelber; A Goldhirsch; K N Price; J Säve-Söderborgh; R Anbazhagan; J Styles; C M Rudenstam; R Golouh; R Reed
Journal:  J Clin Oncol       Date:  1992-07       Impact factor: 44.544

8.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

Authors:  P P Di Fiore; J H Pierce; M H Kraus; O Segatto; C R King; S A Aaronson
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

9.  c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.

Authors:  D Yu; S S Wang; K M Dulski; C M Tsai; G L Nicolson; M C Hung
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

10.  Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Authors:  M F Press; C Cordon-Cardo; D J Slamon
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

View more
  9 in total

1.  Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables.

Authors:  J Decock; W Hendrickx; H Wildiers; M R Christiaens; P Neven; M Drijkoningen; R Paridaens
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Limitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics.

Authors:  Patrick Thurner; Christian Nanoff
Journal:  Breast Care (Basel)       Date:  2008-11-25       Impact factor: 2.860

Review 3.  Chemotherapy for metastatic tumors to the central nervous system.

Authors:  C A Conrad
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

4.  A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation.

Authors:  Hyunjae Lee; Woohyun Park; Hyunryul Ryu; Noo Li Jeon
Journal:  Biomicrofluidics       Date:  2014-09-04       Impact factor: 2.800

5.  The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis.

Authors:  Kai Bartkowiak; Sabine Riethdorf; Klaus Pantel
Journal:  Cancer Microenviron       Date:  2011-05-31

Review 6.  The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis.

Authors:  S A Eccles
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

Review 7.  Stepping out of the flow: capillary extravasation in cancer metastasis.

Authors:  Fayth L Miles; Freddie L Pruitt; Kenneth L van Golen; Carlton R Cooper
Journal:  Clin Exp Metastasis       Date:  2007-09-29       Impact factor: 5.150

8.  CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration.

Authors:  Ke Zen; Dan-Qing Liu; Ya-Lan Guo; Chen Wang; Jun Shan; Ming Fang; Chen-Yu Zhang; Yuan Liu
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

9.  A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44.

Authors:  Irina S Babina; Elaine A McSherry; Simona Donatello; Arnold D K Hill; Ann M Hopkins
Journal:  Breast Cancer Res       Date:  2014-02-10       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.